Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms (2022)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; VICARI, HUGO PASSOS - ICB ; LIMA, KELI CRISTINA DE - FM
- Unidades: ICB; FM
- DOI: 10.3390/cancers14246080
- Subjects: FARMACOLOGIA; LEUCEMIA; ANTINEOPLÁSICOS; MICROTÚBULOS; LEUCÓCITOS; GLICOPROTEÍNAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
VICARI, Hugo Passos et al. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, v. 14, n. 24, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14246080. Acesso em: 11 fev. 2026. -
APA
Vicari, H. P., Lima, K., Costa-Lotufo, L. V., & Machado Neto, J. A. (2022). Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, 14( 24), 1-15. doi:10.3390/cancers14246080 -
NLM
Vicari HP, Lima K, Costa-Lotufo LV, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2026 fev. 11 ] Available from: https://doi.org/10.3390/cancers14246080 -
Vancouver
Vicari HP, Lima K, Costa-Lotufo LV, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2026 fev. 11 ] Available from: https://doi.org/10.3390/cancers14246080 - New molecular targets in acute leukemias: cytoskeletal regulatory proteins
- CDC7 (cell division cycle 7)
- Inibição farmacológica de ezrina reduz a viabilidade, a clonogenicidade e a ativação da via PI3K/AKT/mTOR em modelos celulares de leucemia mieloide aguda
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
- In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia
- Cyclopenta [b] indoles as novel antimicrotubule agents with antileukemia activity
- Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes
- Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
- Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
- The survivin/XIAP suppressant YM155 impairs clonal growth and induces apoptosis in JAK2V617F cells
Informações sobre o DOI: 10.3390/cancers14246080 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Cellular and Molecular Ef... | Direct link | |
|
Cellular and Molecular Ef... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
